Fosamax further defines the obligation of drug manufacturers to present clear, unambiguous, and accurate information to the ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be ... but not approved or inspected by the FDA. Drug compounding is allowed when ...